Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors
Tango Therapeutics, Inc.
Tango Therapeutics, Inc.
Novartis
Kivu Bioscience Inc.
Tango Therapeutics, Inc.
Instituto do Cancer do Estado de São Paulo
Alliance for Clinical Trials in Oncology
Turning Point Therapeutics, Inc.
Actuate Therapeutics Inc.
AstraZeneca
Memorial Sloan Kettering Cancer Center
National Institutes of Health Clinical Center (CC)
M.D. Anderson Cancer Center
Hoffmann-La Roche
Endeavor Biomedicines, Inc.
City of Hope Medical Center
Aveni Foundation
University of California, Irvine
M.D. Anderson Cancer Center
ViroMissile, Inc.
Washington University School of Medicine
Essen Biotech
MacroGenics
City of Hope Medical Center
University of Nebraska
Adela, Inc
Perspective Therapeutics
M.D. Anderson Cancer Center
Ocellaris Pharma, Inc.
Eli Lilly and Company
Var2 Pharmaceuticals
UNICANCER
Tanabe Pharma America, Inc.
Transgene
HiFiBiO Therapeutics
TScan Therapeutics, Inc.
Shasqi, Inc.
Bayer
M.D. Anderson Cancer Center
Actym Therapeutics, Inc.
Hadassah Medical Organization
British Columbia Cancer Agency
Washington University School of Medicine
Valo Therapeutics Oy
Epkin
Guangzhou FineImmune Biotechnology Co., LTD.
Institut Bergonié
GONGCHU Biotechnology Co., Ltd
Sensei Biotherapeutics, Inc.
Jonsson Comprehensive Cancer Center
Washington University School of Medicine